Omega Healthcare Investors Terminates Material Agreement

TL;DR

OHI terminated a big deal, details TBD.

AI Summary

Omega Healthcare Investors, Inc. (OHI) filed an 8-K on October 15, 2025, to report the termination of a material definitive agreement. The filing does not provide specific details about the agreement or the parties involved, only that it has been terminated.

Why It Matters

The termination of a material definitive agreement can signal significant changes in a company's contractual relationships, potentially impacting its operations, financial standing, or future strategies.

Risk Assessment

Risk Level: medium — The termination of a material definitive agreement, without further details, introduces uncertainty about the company's business relationships and financial commitments.

Key Players & Entities

• Omega Healthcare Investors, Inc. (company) — Registrant
• October 15, 2025 (date) — Date of Report

FAQ

From the Filing

0000888491-25-000034.txt : 20251015 0000888491-25-000034.hdr.sgml : 20251015 20251015161611 ACCESSION NUMBER: 0000888491-25-000034 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20251015 ITEM INFORMATION: Termination of a Material Definitive Agreement FILED AS OF DATE: 20251015 DATE AS OF CHANGE: 20251015 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMEGA HEALTHCARE INVESTORS INC CENTRAL INDEX KEY: 0000888491 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction EIN: 383041398 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11316 FILM NUMBER: 251395001 BUSINESS ADDRESS: STREET 1: 303 INTERNATIONAL CIRCLE, STREET 2: SUITE 200 CITY: HUNT VALLEY STATE: MD ZIP: 21030 BUSINESS PHONE: 410-427-1700 MAIL ADDRESS: STREET 1: 303 INTERNATIONAL CIRCLE, STREET 2: SUITE 200 CITY: HUNT VALLEY STATE: MD ZIP: 21030 8-K 1 ohi-20251015x8k.htm 8-K OMEGA HEALTHCARE INVESTORS, INC._October 15, 2025 0000888491 false 0000888491 2025-10-15 2025-10-15 ​ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K ​ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ​ Date of Report (Date of earliest event reported): October 15, 2025 ​ OMEGA HEALTHCARE INVESTORS, INC. (Exact name of registrant as specified in its charter) ​ Maryland 1-11316 38-3041398 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) ​ 303 International Circle, Suite 200 Hunt Valley , Maryland 21030 (Address of principal executive offices / Zip Code) ​ ( 410 ) 427-1700 (Registrant’s telephone number, including area code) ​ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐      Written communications pursuant to Rule 425 under the Securities Act. ☐      Soliciting material pursuant to Rule 14a-12 under the Exchange Act. ☐      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act. ☐      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act. Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934: ​ Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.10 par value OHI New York Stock Exchange ​ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ​ Emerging growth company  ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ ​ ​ Item 1.02 Termination of a Material Definitive Agreement. ​ On October 15, 2025, Omega Healthcare Investors, Inc. (“Omega”) redeemed all of the $600 million aggregate principal amount of its outstanding 5.250% Senior Notes due 2026 (the “Notes”). The Notes were originally issued under an Indenture dated as of September 23, 2015, as amended and supplemented, or the Indenture, by and among Omega, certain of its subsidiaries, as guarantors, and U.S. Bank Trust Company, National Association, as Trustee. ​ As previously reported, on September 15, 2025, at Omega’s direction, the Trustee gave notice to the holders of the Notes of Omega’s election to redeem all of the Not